Integra Lifesciences: FDA 510(k) Clearances, Shared Predicate Lineage, and Recall History (1999 to 2025)

Consolidated U.S. FDA 510(k) premarket clearance cohort in Neurology (primary filing hub: NJ) reconciled with CDRH and openFDA historical recall notices from 1999 to 2025.

Review 94 FDA 510(k) clearances, 26 recalled K-numbers, and 316 cumulative 1976 to 2026 CDRH recall notices for Integra Lifesciences on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for Integra Lifesciences
Regulatory MetricVerified Value
Entity ClassificationFDA 510(k) Applicant Manufacturer
Clinical Advisory SpecialtyNeurology (Panel NE)
Cleared FDA 510(k) Submissions (1976 to 2026)94 clearances (0 California, 0.0%)
Cleared 510(k)s Linked to a Recall Notice26 K-numbers (27.66% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)316 notices (5 Class I, 308 Class II, 3 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (316 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances48 implantable (51.1%) and 0 life-sustaining
Median FDA 510(k) Review Duration82 days (90th percentile: 261 days)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Integra LifeSciences across sibling Meru public-data platforms.

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.